Insider Transactions last 24 months for Prelude Therapeutics Incorporated  -  NSDQ: PRLD

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Huang JanePresident, CMO10/04/2025DFDirectCOM3,355$1.47$4,931.8586,917
Huang JanePresident, CMO10/04/2025AMDirectCOM9,375$0.00$0.0090,272
Huang JanePresident, CMO07/04/2025DFDirectCOM3,355$0.79$2,663.5380,897
Huang JanePresident, CMO07/04/2025AMDirectCOM9,375$0.00$0.0084,252
Huang JanePresident, CMO04/04/2025DFDirectCOM3,355$0.68$2,264.6374,877
Huang JanePresident, CMO04/04/2025AMDirectCOM9,375$0.00$0.0078,232
Vaddi KrishnaCEO03/25/2025APDirectCOM675,000$0.69$467,437.501,999,296
Combs AndrewChief Chemistry Officer03/25/2025APDirectCOM100,000$0.69$69,250.00480,123
Vaddi KrishnaCEO03/21/2025APDirectCOM15,000$0.73$10,959.001,324,296
Vaddi KrishnaCEO03/20/2025APDirectCOM5,416$0.73$3,950.431,309,296
Vaddi KrishnaCEO03/17/2025APDirectCOM9,106$0.75$6,828.591,303,880
Vaddi KrishnaCEO03/14/2025APDirectCOM29,999$0.75$22,631.251,294,774
Vaddi KrishnaCEO03/13/2025APDirectCOM50,000$0.72$35,820.001,264,775
Vaddi KrishnaCEO03/12/2025APDirectCOM47,500$0.71$33,744.001,214,775
Vaddi KrishnaCEO12/31/2024APIndirectCOM5,000$1.21$6,043.50142,553
Combs AndrewChief Chemistry Officer12/23/2024APDirectCOM60,000$1.37$82,002.00377,623
Combs AndrewChief Chemistry Officer12/20/2024APDirectCOM3,075$1.15$3,536.25317,623
Vaddi KrishnaCEO12/19/2024APIndirectCOM6,888$0.89$6,115.86127,553
Lim Bryant DavidCLO, Interim CFO, Corp Sec.12/19/2024APDirectCOM25,000$0.91$22,637.5027,400
Vaddi KrishnaCEO12/18/2024APDirectCOM100,000$0.93$93,210.001,167,275
Huang JanePresident, CMO10/04/2024DFDirectCOM3,349$2.00$6,698.0063,341
Huang JanePresident, CMO10/04/2024AMDirectCOM9,375$0.00$0.0066,690
Huang JanePresident, CMO07/04/2024DFDirectCOM3,347$3.60$12,049.2057,315
Huang JanePresident, CMO07/04/2024AMDirectCOM9,375$0.00$0.0060,662
Huang JanePresident, CMO04/04/2024DFDirectCOM3,347$4.74$15,864.7851,287
1   2  Next Last  You are at page 1 of 2 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel